CMMC Phase 1 began Nov. 10, and major defense primary contractors are already demanding compliance from their suppliers.
Huntsman Cancer Institute at the University of Utah stands at the forefront of innovative cancer research and treatment. Phase 1 clinical trials are key to finding better ways to treat cancer safely ...
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in ...
Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants -- ...
10don MSN
Beam Therapeutics Inc. (BEAM) Reports Updated Data From BEACON Phase 1/2 trial Of Ristoglogene
Beam Therapeutics Inc. (NASDAQ: BEAM) is among the 12 Best Genomics Stocks to Invest In.
NRG Therapeutics Ltd. ('NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial ...
Actuate Therapeutics (ACTU) announced results from the phase 1 portion of its phase 1/2 clinical study evaluating elraglusib as a monotherapy or ...
Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback